Andrea Wang-Gillam, Co-CEO at Jacobio Pharma, shared on LinkedIn:
“It was such a pleasure to attend the inaugural AACR D3 meeting! Great to reconnect with friends, colleagues, meet potential collaborators, and learn from each other on the exciting advances in oncology drug discovery!
I was also proud to present our team work on tADC and truly appreciated the thoughtful feedbacks.
Looking forward to seeing everyone at the next AACR D3 meeting.”